Vascular pathology may accelerate the progression of AD by reducing cerebral perfusion, disrupting the integrity of the blood–brain barrier (BBB), and promoting the deposition of amyloid-β and tau proteins (Stakos et al., 2020). Here, MAPT is linked to Alzheimer disease.